| Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia (NCT02411578) | Jaeb Center for Health Research | 2015-09-01 |
| Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus (NCT02536859) | Novo Nordisk A/S | 2015-08-31 |
| Three-dimensional Measurements of Diabetic Foot Ulcers (NCT02423850) | Odense University Hospital | 2015-08-01 |
| Carbohydrate Estimation Supported by the GoCARB System (NCT02546063) | Insel Gruppe AG, University Hospital Bern | 2015-08-01 |
| Evolution of Effectiveness of Diabetes Medical Care in Russia (NCT02574195) | Endocrinology Research Centre, Moscow | 2015-08-01 |
| Pre-POINT-Early Study (NCT02547519) | Technical University of Munich | 2015-08-01 |
| An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas (NCT02536950) | Bruce A. Buckingham | 2015-08-01 |
| A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India (NCT02117622) | Novo Nordisk A/S | 2015-07-24 |
| Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients (NCT04078308) | Royan Institute | 2015-07-06 |
| GLUCOME USABILITY STUDY (NCT02488278) | GlucoMe | 2015-07-01 |
| BGAT (Blood Glucose Awareness Training) for Users Who Might Become Pregnant (NCT02508779) | University of Virginia | 2015-07-01 |
| Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients (NCT02861157) | 3-C Institute for Social Development | 2015-07-01 |
| Standardized Evaluation of Subcutaneous Glucose Monitoring Systems Under Routine Environmental Conditions (NCT02614768) | Medical University of Graz | 2015-07-01 |
| Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) (NCT02414958) | Boehringer Ingelheim | 2015-06-30 |
| Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections (NCT02465411) | Vastra Gotaland Region | 2015-06-01 |
| Evaluation of a Flash Glucose Monitoring System in Ambulatory Patients With Type 1 Diabetes (NCT02677454) | Vastra Gotaland Region | 2015-06-01 |
| Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes (NCT02403375) | Hoffmann-La Roche | 2015-05-17 |
| EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes (NCT02464033) | Johnny Ludvigsson | 2015-05-01 |
| Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting (NCT02463682) | Sansum Diabetes Research Institute | 2015-05-01 |
| Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign (NCT03068273) | Scripps Whittier Diabetes Institute | 2015-05-01 |
| Development of a Comprehensive AP Training Curriculum for Adults (NCT02434094) | University of Virginia | 2015-04-01 |
| Minimal Islet Transplant at Diabetes Onset (NCT02505893) | Ospedale San Raffaele | 2015-04-01 |
| Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE (NCT03607604) | Imperial College London Diabetes Centre | 2015-04-01 |
| Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus (NCT02392117) | Novo Nordisk A/S | 2015-03-16 |
| Cognitive-Behavioral Therapy (CBT) in Children With Diabetes (NCT02839031) | University Hospital, Montpellier | 2015-03-11 |
| Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies (NCT02387164) | Lund University | 2015-03-09 |
| Type 1 Diabetes and the Brain in Children (NCT02351466) | Nemours Children's Clinic | 2015-03-01 |
| What is the Dose Response of Varying Meal Content of Fat on Postprandial Glycaemia in Children With T1DM? (NCT02371694) | Cork University Hospital | 2015-02-01 |
| Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal (NCT02344992) | Adocia | 2015-01-01 |
| GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1) (NCT02352974) | Johnny Ludvigsson | 2015-01-01 |
| Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care (NCT02225691) | Shanghai 6th People's Hospital | 2014-12-01 |
| ATG-GCSF in New Onset Type 1 Diabetes (NCT02215200) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-12-01 |
| Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options (NCT02365740) | Federico II University | 2014-11-01 |
| Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems (NCT02283411) | Abbott Diabetes Care | 2014-11-01 |
| Different Dietary Interventions and Glycemia in T1DM (NCT04343131) | National and Kapodistrian University of Athens | 2014-11-01 |
| A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes (NCT02306681) | Novo Nordisk A/S | 2014-10-30 |
| Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus (NCT02284009) | GlaxoSmithKline | 2014-10-10 |
| Children With Diabetes at Risk for Heart Disease. (NCT02275091) | Georgetown University | 2014-10-01 |
| Resilient, Empowered, Active Living: REAL Diabetes Study (NCT02214641) | University of Southern California | 2014-10-01 |
| A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes (NCT02230631) | Novo Nordisk A/S | 2014-10-01 |
| Tailored Diabetes Self-Management Resources (NCT02024750) | University of Wisconsin, Madison | 2014-09-01 |
| Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes (NCT02232971) | Hvidovre University Hospital | 2014-09-01 |
| The Link Between "Time In Range" Versus HbA1c and the Presence of Chronic COmplications in Type 1 Diabetes: a Longitudinal Study (NCT05530369) | University Hospital, Antwerp | 2014-09-01 |
| Diabetes Intervention Program for Adolescents With Persistent High HA1c (NCT02212158) | University of Manitoba | 2014-09-01 |
| Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents (NCT03199716) | University of California, Davis | 2014-09-01 |
| Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop (NCT02328040) | Albert Einstein College of Medicine | 2014-09-01 |
| Closing the Loop 24/7 in Adolescents With Type 1 Diabetes (NCT01873066) | University of Cambridge | 2014-08-28 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus (NCT02220296) | Novo Nordisk A/S | 2014-08-20 |
| A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes (NCT02213146) | Adocia | 2014-08-01 |
| Evaluation of Novel Trend Arrow Adjustment Tool for Diabetes Patients Using Continuous Glucose Monitoring to Guide Insulin Bolus Adjustment (TAAT Study) (NCT02064647) | Children's Hospital of Eastern Ontario | 2014-07-01 |
| Educational Efficacy Assessment of a Serious Game to Teach Insulin Therapy to Primary Care Physicians (NCT01759953) | Universidade Estadual de Londrina | 2014-07-01 |
| A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements (NCT02152384) | Eli Lilly and Company | 2014-06-01 |
| A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis (NCT02157155) | University of Aarhus | 2014-06-01 |
| Assessment of an Automatic Closed-loop Insulin Delivery System (NCT02366767) | Stanford University | 2014-06-01 |
| A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes (NCT02806960) | Eli Lilly and Company | 2014-06-01 |
| Full Day and Night Closed-Loop With DiAs Platform (NCT02147860) | University of Virginia | 2014-05-01 |
| Treatment of Diabetic Neuropathy With Liraglutide (NCT02138045) | Aalborg University Hospital | 2014-05-01 |
| A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM) (NCT02139943) | Janssen Research & Development, LLC | 2014-05-01 |
| A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02131246) | Novo Nordisk A/S | 2014-05-01 |
| A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes (NCT02146651) | Adocia | 2014-05-01 |
| MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes (NCT02545062) | Clalit Health Services | 2014-05-01 |
| The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes (NCT02098395) | Novo Nordisk A/S | 2014-05-01 |
| Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM) (NCT02138331) | General Committee of Teaching Hospitals and Institutes, Egypt | 2014-04-01 |
| A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue (NCT02109029) | Eli Lilly and Company | 2014-04-01 |
| Sequencing T-cells in Type I Diabetes Mellitus (NCT02040337) | Seton Healthcare Family | 2014-04-01 |
| Automated Closed-loop in Children and Adolescents With Type 1 Diabetes (NCT02129868) | University of Cambridge | 2014-04-01 |
| Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients (NCT02000817) | GlaxoSmithKline | 2014-03-12 |
| Improving Postprandial Glycaemia by a New Developed Closed-loop Control System - Closedloop4meals (NCT02100488) | Fundación para la Investigación del Hospital Clínico de Valencia | 2014-03-01 |
| A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics (NCT02094534) | Oramed, Ltd. | 2014-03-01 |
| Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus (NCT02644759) | Stem Cells Arabia | 2014-02-01 |
| AbATE Follow-Up Study (NCT02067923) | Yale University | 2014-02-01 |
| Liraglutide in Newly Onset Type 1 Diabetes. (NCT01879917) | Hvidovre University Hospital | 2014-02-01 |
| A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (NCT02034513) | Novo Nordisk A/S | 2014-01-05 |
| A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02033239) | Novo Nordisk A/S | 2014-01-01 |
| CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections (NCT02092051) | Vastra Gotaland Region | 2014-01-01 |
| Effects of Low Intensity Aerobic Exercise on the Microvascular Endothelial Function of Patients With Type 1 Diabetes (NCT02441504) | Instituto Nacional de Cardiologia de Laranjeiras | 2014-01-01 |
| Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting (NCT01778348) | University of Cambridge | 2013-12-01 |
| A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes (NCT02029924) | Adocia | 2013-12-01 |
| A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes (NCT01999322) | Novo Nordisk A/S | 2013-11-19 |
| Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba® (NCT01984372) | Novo Nordisk A/S | 2013-11-06 |
| Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days (NCT01969747) | Boehringer Ingelheim | 2013-11-01 |
| Periodontal and Salivary Evaluation of Type 1 Diabetes Mellitus Patients (NCT02935868) | University of Sao Paulo | 2013-11-01 |
| Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes (NCT02127047) | University Hospital, Basel, Switzerland | 2013-11-01 |
| Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults (NCT01994746) | Eli Lilly and Company | 2013-11-01 |
| A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes (NCT01981031) | Adocia | 2013-11-01 |
| Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes (NCT01997411) | Eli Lilly and Company | 2013-11-01 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes (NCT01992588) | Novo Nordisk A/S | 2013-11-01 |
| The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes (NCT01836523) | Novo Nordisk A/S | 2013-11-01 |
| A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus (NCT01835431) | Novo Nordisk A/S | 2013-10-17 |
| A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes (NCT01771250) | Eli Lilly and Company | 2013-10-01 |
| A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes (NCT01934712) | Novo Nordisk A/S | 2013-08-30 |
| Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes (NCT01831765) | Novo Nordisk A/S | 2013-08-26 |
| Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages (NCT01916265) | Profil Institut für Stoffwechselforschung GmbH | 2013-08-01 |
| The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus (NCT04253431) | HTL-Strefa S.A. | 2013-08-01 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes (NCT01924637) | Novo Nordisk A/S | 2013-08-01 |
| Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass (NCT02236754) | Columbia University | 2013-07-02 |
| Pharmacokinetics Study of Gamma-aminobutyric Acid (NCT01917760) | Huashan Hospital | 2013-07-01 |
| Assessment of an iPhone Application on Glycemic Control in Type 1 Diabetes (NCT01899274) | The Hospital for Sick Children | 2013-07-01 |
| Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period (NCT01900834) | Novo Nordisk A/S | 2013-07-01 |
| Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus (NCT01839370) | University of Virginia | 2013-07-01 |